Home » Newsletters » BioWorld Asia

BioWorld Asia

June 9, 1999

View Archived Issues

SmithKline Passes On Vaccine Being Developed By Amrad

Polymorphism In TNF Promoter Increases Likelihood Of Malaria

Commission Suggests More Controls On Biotech Products

Cerebrus Licenses Alzheimers Drug Thats Reached Phase III

CAT Issues Aptein More Shares

Surveys Show Biotech Out Of Favor With Most Europeans

Relenzas European Approval Helps Renew Interest In Biota

MediGene Validates Target Involved In Heart Failure

TAB Seeks Partner To Move Sepsis Product Into Phase III

Theratechnologies To Create Subsidiary Based On Peptides

LION Adds To Platform, Completes Licensing Deal

Oxford Biomedica Shows Genes Carried to HIV Cells

Shield, Axis Complete Merger, To Focus On In Vitro Products

Pharming Group Prepares To Start Phase III Study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...